The lower average LAG3 protein levels in metastatic sites compared to primary tumors need to be cautiously interpreted in the context of findings from Braun et al, which showed that more advanced stages of RCC are more highly enriched with exhausted CD8+ T cell populations, characterized by high expression of multiple immune checkpoints, including LAG3 (12). The gene discussed is LAG3; the disease is renal cell carcinoma.